{"id":259740,"date":"2021-06-22T18:44:45","date_gmt":"2021-06-22T21:44:45","guid":{"rendered":"https:\/\/www.notibras.com\/site\/?p=259740"},"modified":"2021-06-22T21:48:14","modified_gmt":"2021-06-23T00:48:14","slug":"anvisa-descarta-uso-de-avifavir-contra-covid","status":"publish","type":"post","link":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/","title":{"rendered":"Anvisa descarta uso de Avifavir contra Covid"},"content":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) negou nesta ter\u00e7a (22) o pedido de autoriza\u00e7\u00e3o tempor\u00e1ria para uso emergencial do medicamento Avifavir (Favipiravir) no tratamento antiviral de pacientes hospitalizados com covid-19. A decis\u00e3o un\u00e2nime foi tomada durante a 12\u00aa reuni\u00e3o p\u00fablica da Diretoria Colegiada (Dicol).<\/p>\n<p>Segundo a relatora, a diretora da ag\u00eancia Meiruze Freitas, o rem\u00e9dio n\u00e3o atende \u00e0s expectativas da ag\u00eancia quanto aos requisitos m\u00ednimos de seguran\u00e7a e efic\u00e1cia no contexto do uso emergencial.<\/p>\n<p>\u201cA Anvisa deve usar de todas as vias poss\u00edveis para fazer com que novos tratamentos estejam dispon\u00edveis para os pacientes o mais r\u00e1pido poss\u00edvel. Entretanto, n\u00e3o se pode autorizar o uso de um medicamento que n\u00e3o demonstrou benef\u00edcio cl\u00ednico no tratamento da covid-19 e ainda pode resultar em riscos \u00e0 sa\u00fade dos pacientes\u201d, afirmou Freitas.<\/p>\n<p>A solicita\u00e7\u00e3o de autoriza\u00e7\u00e3o de uso emergencial do Avifavir foi feita pelo Instituto Vital Brazil, representante no Brasil do medicamento, fabricado pelas empresas russas API \u2013 Technologies LLC e Joint Stock Company Chemical Diversity Research Institute.<\/p>\n<p>Em nota, a Anvisa justificou a decis\u00e3o afirmando que o medicamento \u00e9 produzido com mat\u00e9ria-prima ainda n\u00e3o registrada pela ag\u00eancia e que nenhuma outra autoridade regulat\u00f3ria de outros pa\u00edses aprovou o Avifavir para o tratamento da covid-19. Al\u00e9m disso, as \u00e1reas t\u00e9cnicas conclu\u00edram que as limita\u00e7\u00f5es, incertezas e riscos da aprova\u00e7\u00e3o do uso emergencial do medicamento superariam os benef\u00edcios no eventual tratamento de pacientes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) negou nesta ter\u00e7a (22) o pedido de autoriza\u00e7\u00e3o tempor\u00e1ria para uso emergencial do medicamento Avifavir (Favipiravir) no tratamento antiviral de pacientes hospitalizados com covid-19. A decis\u00e3o un\u00e2nime foi tomada durante a 12\u00aa reuni\u00e3o p\u00fablica da Diretoria Colegiada (Dicol). Segundo a relatora, a diretora da ag\u00eancia Meiruze Freitas, o [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":259741,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[16],"tags":[],"tmauthors":[],"class_list":["post-259740","post","type-post","status-publish","format-standard","has-post-thumbnail","category-brasil"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa descarta uso de Avifavir contra Covid - Notibras<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa descarta uso de Avifavir contra Covid - Notibras\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) negou nesta ter\u00e7a (22) o pedido de autoriza\u00e7\u00e3o tempor\u00e1ria para uso emergencial do medicamento Avifavir (Favipiravir) no tratamento antiviral de pacientes hospitalizados com covid-19. A decis\u00e3o un\u00e2nime foi tomada durante a 12\u00aa reuni\u00e3o p\u00fablica da Diretoria Colegiada (Dicol). Segundo a relatora, a diretora da ag\u00eancia Meiruze Freitas, o [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/\" \/>\n<meta property=\"og:site_name\" content=\"Notibras\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/notibras\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T21:44:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-23T00:48:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2021\/06\/Avifavir_1748206655-e1599195163197.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Reda\u00e7\u00e3o\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Notibras\" \/>\n<meta name=\"twitter:site\" content=\"@Notibras\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reda\u00e7\u00e3o\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/\"},\"author\":{\"name\":\"Reda\u00e7\u00e3o\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#\\\/schema\\\/person\\\/36ab0979449956132d3e5b517ea76ac8\"},\"headline\":\"Anvisa descarta uso de Avifavir contra Covid\",\"datePublished\":\"2021-06-22T21:44:45+00:00\",\"dateModified\":\"2021-06-23T00:48:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/\"},\"wordCount\":272,\"publisher\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Avifavir_1748206655-e1599195163197.jpg\",\"articleSection\":[\"Brasil\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/\",\"url\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/\",\"name\":\"Anvisa descarta uso de Avifavir contra Covid - Notibras\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Avifavir_1748206655-e1599195163197.jpg\",\"datePublished\":\"2021-06-22T21:44:45+00:00\",\"dateModified\":\"2021-06-23T00:48:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Avifavir_1748206655-e1599195163197.jpg\",\"contentUrl\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Avifavir_1748206655-e1599195163197.jpg\",\"width\":1600,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/anvisa-descarta-uso-de-avifavir-contra-covid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa descarta uso de Avifavir contra Covid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/\",\"name\":\"Notibras\",\"description\":\"Not\u00edcias de Bras\u00edlia, do Brasil e do Mundo\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#organization\",\"name\":\"Grupo Notibras de Comunica\u00e7\u00e3o\",\"url\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/notibras23.png\",\"contentUrl\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/notibras23.png\",\"width\":350,\"height\":87,\"caption\":\"Grupo Notibras de Comunica\u00e7\u00e3o\"},\"image\":{\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/notibras\\\/\",\"https:\\\/\\\/x.com\\\/Notibras\",\"https:\\\/\\\/www.instagram.com\\\/notibras\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.notibras.com\\\/site\\\/#\\\/schema\\\/person\\\/36ab0979449956132d3e5b517ea76ac8\",\"name\":\"Reda\u00e7\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e0a867bdedb85fd243eadf09663511f96fc81e0720a4a42581f334ad4303aa6b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e0a867bdedb85fd243eadf09663511f96fc81e0720a4a42581f334ad4303aa6b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e0a867bdedb85fd243eadf09663511f96fc81e0720a4a42581f334ad4303aa6b?s=96&d=mm&r=g\",\"caption\":\"Reda\u00e7\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa descarta uso de Avifavir contra Covid - Notibras","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa descarta uso de Avifavir contra Covid - Notibras","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) negou nesta ter\u00e7a (22) o pedido de autoriza\u00e7\u00e3o tempor\u00e1ria para uso emergencial do medicamento Avifavir (Favipiravir) no tratamento antiviral de pacientes hospitalizados com covid-19. A decis\u00e3o un\u00e2nime foi tomada durante a 12\u00aa reuni\u00e3o p\u00fablica da Diretoria Colegiada (Dicol). Segundo a relatora, a diretora da ag\u00eancia Meiruze Freitas, o [&hellip;]","og_url":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/","og_site_name":"Notibras","article_publisher":"https:\/\/www.facebook.com\/notibras\/","article_published_time":"2021-06-22T21:44:45+00:00","article_modified_time":"2021-06-23T00:48:14+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2021\/06\/Avifavir_1748206655-e1599195163197.jpg","type":"image\/jpeg"}],"author":"Reda\u00e7\u00e3o","twitter_card":"summary_large_image","twitter_creator":"@Notibras","twitter_site":"@Notibras","twitter_misc":{"Escrito por":"Reda\u00e7\u00e3o","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#article","isPartOf":{"@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/"},"author":{"name":"Reda\u00e7\u00e3o","@id":"https:\/\/www.notibras.com\/site\/#\/schema\/person\/36ab0979449956132d3e5b517ea76ac8"},"headline":"Anvisa descarta uso de Avifavir contra Covid","datePublished":"2021-06-22T21:44:45+00:00","dateModified":"2021-06-23T00:48:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/"},"wordCount":272,"publisher":{"@id":"https:\/\/www.notibras.com\/site\/#organization"},"image":{"@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2021\/06\/Avifavir_1748206655-e1599195163197.jpg","articleSection":["Brasil"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/","url":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/","name":"Anvisa descarta uso de Avifavir contra Covid - Notibras","isPartOf":{"@id":"https:\/\/www.notibras.com\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#primaryimage"},"image":{"@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#primaryimage"},"thumbnailUrl":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2021\/06\/Avifavir_1748206655-e1599195163197.jpg","datePublished":"2021-06-22T21:44:45+00:00","dateModified":"2021-06-23T00:48:14+00:00","breadcrumb":{"@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#primaryimage","url":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2021\/06\/Avifavir_1748206655-e1599195163197.jpg","contentUrl":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2021\/06\/Avifavir_1748206655-e1599195163197.jpg","width":1600,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.notibras.com\/site\/anvisa-descarta-uso-de-avifavir-contra-covid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.notibras.com\/site\/"},{"@type":"ListItem","position":2,"name":"Anvisa descarta uso de Avifavir contra Covid"}]},{"@type":"WebSite","@id":"https:\/\/www.notibras.com\/site\/#website","url":"https:\/\/www.notibras.com\/site\/","name":"Notibras","description":"Not\u00edcias de Bras\u00edlia, do Brasil e do Mundo","publisher":{"@id":"https:\/\/www.notibras.com\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.notibras.com\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.notibras.com\/site\/#organization","name":"Grupo Notibras de Comunica\u00e7\u00e3o","url":"https:\/\/www.notibras.com\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.notibras.com\/site\/#\/schema\/logo\/image\/","url":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2023\/01\/notibras23.png","contentUrl":"https:\/\/www.notibras.com\/site\/wp-content\/uploads\/2023\/01\/notibras23.png","width":350,"height":87,"caption":"Grupo Notibras de Comunica\u00e7\u00e3o"},"image":{"@id":"https:\/\/www.notibras.com\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/notibras\/","https:\/\/x.com\/Notibras","https:\/\/www.instagram.com\/notibras\/"]},{"@type":"Person","@id":"https:\/\/www.notibras.com\/site\/#\/schema\/person\/36ab0979449956132d3e5b517ea76ac8","name":"Reda\u00e7\u00e3o","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/e0a867bdedb85fd243eadf09663511f96fc81e0720a4a42581f334ad4303aa6b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e0a867bdedb85fd243eadf09663511f96fc81e0720a4a42581f334ad4303aa6b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e0a867bdedb85fd243eadf09663511f96fc81e0720a4a42581f334ad4303aa6b?s=96&d=mm&r=g","caption":"Reda\u00e7\u00e3o"}}]}},"_links":{"self":[{"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/posts\/259740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/comments?post=259740"}],"version-history":[{"count":1,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/posts\/259740\/revisions"}],"predecessor-version":[{"id":259742,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/posts\/259740\/revisions\/259742"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/media\/259741"}],"wp:attachment":[{"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/media?parent=259740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/categories?post=259740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/tags?post=259740"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/www.notibras.com\/site\/wp-json\/wp\/v2\/tmauthors?post=259740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}